Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity

William W Du1,2, Ling Fang1,2,3, Weining Yang1

  • 1Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

Insights

Circular RNAs (circRNAs) like circ-Foxo3 are key regulators. This study reveals circ-Foxo3 suppresses tumor growth by stabilizing Foxo3 protein, promoting apoptosis in cancer cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are a novel class of non-coding RNAs with largely unknown functions.
  • While some circRNAs act as miRNA sponges, their roles in cancer biology are under investigation.

Purpose of the Study:

  • To investigate the role of circ-Foxo3 in cancer development and apoptosis.
  • To elucidate the molecular mechanism by which circ-Foxo3 influences protein stability and cell fate.

Main Methods:

  • Analysis of circ-Foxo3 expression in patient tumor samples and cancer cell lines.
  • Manipulation of endogenous and ectopic circ-Foxo3 levels to assess effects on cell viability and apoptosis.
  • Investigation of circ-Foxo3 interactions with Foxo3 and p53 proteins and their regulators (e.g., MDM2).

Main Results:

  • Circ-Foxo3 expression is significantly increased during cancer cell apoptosis and minimally expressed in tumors.
  • Silencing circ-Foxo3 enhances cancer cell viability, while its ectopic expression induces apoptosis and inhibits tumor xenograft growth.
  • Circ-Foxo3 stabilizes Foxo3 protein by preventing MDM2-mediated degradation, leading to increased PUMA expression and apoptosis.
  • Circ-Foxo3 promotes p53 degradation by facilitating MDM2-induced ubiquitination.

Conclusions:

  • Circ-Foxo3 acts as a tumor suppressor by stabilizing Foxo3 protein and inducing apoptosis.
  • The findings highlight circ-Foxo3 as a potential therapeutic target for cancer treatment.
  • Circ-Foxo3's distinct regulatory effects on Foxo3 and p53 protein levels offer insights into its complex role in cancer progression.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.5K